TY - JOUR
T1 - Enzyme-linked immunosorbent assays for detection of equine antibodies specific to Sarcocystis neurona surface antigens
AU - Hoane, Jessica S.
AU - Morrow, Jennifer K.
AU - Saville, William J.
AU - Dubey, J. P.
AU - Granstrom, David E.
AU - Howe, Daniel K.
PY - 2005/9
Y1 - 2005/9
N2 - Sarcocystis neurona is the primary causative agent of equine protozoal myeloenceplialitis (EPM), a common neurologic disease of horses in the Americas. We have developed a set of enzyme-linked immenosorbent assays (ELISAs) based on the four major surface antigens of S. neurona (SnSAGs) to analyze the equine antibody response to S. neurona. The SnSAG ELISAs were optimized and standardized with a sample set of 36 equine sera that had been characterized by Western blotting against total S. neurona parasite antigen, the current gold standard for S. neurona serology. The recombinant SnSAG2 (rSnSAG2) ELISA showed the highest sensitivity and specificity at 95.5% and 92.9%, respectively. In contrast, only 68.2% sensitivity and 71.4% specificity were achieved with the rSnSAG1 ELISA, indicating that this antigen may not be a reliable serological marker for analyzing antibodies against S. neurona in horses. Importantly, the ELISA antigens did not show cross-reactivity with antisera to Sarcocystis fayeri or Neospora hughesi, two other equine parasites. The accuracy and reliability exhibited by the SnSAG ELISAs suggest that these assays will be valuable tools for examining the equine immune response against S. neurona infection, which may help in understanding the pathobiology of this accidental parasite-host interaction. Moreover, with modification and further investigation, the SnSAG ELISAs have potential for use as immunodiagnostic tests to aid in the identification of horses affected by EPM.
AB - Sarcocystis neurona is the primary causative agent of equine protozoal myeloenceplialitis (EPM), a common neurologic disease of horses in the Americas. We have developed a set of enzyme-linked immenosorbent assays (ELISAs) based on the four major surface antigens of S. neurona (SnSAGs) to analyze the equine antibody response to S. neurona. The SnSAG ELISAs were optimized and standardized with a sample set of 36 equine sera that had been characterized by Western blotting against total S. neurona parasite antigen, the current gold standard for S. neurona serology. The recombinant SnSAG2 (rSnSAG2) ELISA showed the highest sensitivity and specificity at 95.5% and 92.9%, respectively. In contrast, only 68.2% sensitivity and 71.4% specificity were achieved with the rSnSAG1 ELISA, indicating that this antigen may not be a reliable serological marker for analyzing antibodies against S. neurona in horses. Importantly, the ELISA antigens did not show cross-reactivity with antisera to Sarcocystis fayeri or Neospora hughesi, two other equine parasites. The accuracy and reliability exhibited by the SnSAG ELISAs suggest that these assays will be valuable tools for examining the equine immune response against S. neurona infection, which may help in understanding the pathobiology of this accidental parasite-host interaction. Moreover, with modification and further investigation, the SnSAG ELISAs have potential for use as immunodiagnostic tests to aid in the identification of horses affected by EPM.
UR - http://www.scopus.com/inward/record.url?scp=24944435396&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=24944435396&partnerID=8YFLogxK
U2 - 10.1128/CDLI.12.9.1050-1056.2005
DO - 10.1128/CDLI.12.9.1050-1056.2005
M3 - Article
C2 - 16148170
AN - SCOPUS:24944435396
SN - 1071-412X
VL - 12
SP - 1050
EP - 1056
JO - Clinical and Diagnostic Laboratory Immunology
JF - Clinical and Diagnostic Laboratory Immunology
IS - 9
ER -